Literature DB >> 26468743

The Quest for a Universal Flu Vaccine: Headless HA 2.0.

Florian Krammer1.   

Abstract

Two recent publications report the design of immunogens based on the conserved stalk domain of the influenza virus hemagglutinin. These new "headless" hemagglutinin constructs recapitulate the epitopes recognized by broadly neutralizing antibodies and induce broadly protective/heterosubtypic immunity in animal models, bringing us a step closer to "universal" influenza virus vaccines.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26468743     DOI: 10.1016/j.chom.2015.10.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  28 in total

1.  Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines.

Authors:  Sinthujan Jegaskanda; Sarah F Andrews; Adam K Wheatley; Jonathan W Yewdell; Adrian B McDermott; Kanta Subbarao
Journal:  JCI Insight       Date:  2019-11-14

Review 2.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

3.  Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.

Authors:  Attapon Kamlangdee; Brock Kingstad-Bakke; Jorge E Osorio
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 4.  Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Authors:  Karlynn E Neu; Carole J Henry Dunand; Patrick C Wilson
Journal:  Curr Opin Immunol       Date:  2016-06-03       Impact factor: 7.486

Review 5.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

Review 6.  Universal influenza virus vaccines and therapeutic antibodies.

Authors:  R Nachbagauer; F Krammer
Journal:  Clin Microbiol Infect       Date:  2017-02-12       Impact factor: 8.067

Review 7.  Novel universal influenza virus vaccine approaches.

Authors:  Florian Krammer
Journal:  Curr Opin Virol       Date:  2016-02-27       Impact factor: 7.090

Review 8.  Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.

Authors:  Saranya Sridhar
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

9.  Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.

Authors:  Lei Deng; Teena Mohan; Timothy Z Chang; Gilbert X Gonzalez; Ye Wang; Young-Man Kwon; Sang-Moo Kang; Richard W Compans; Julie A Champion; Bao-Zhong Wang
Journal:  Nat Commun       Date:  2018-01-24       Impact factor: 14.919

10.  Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.

Authors:  Yo Han Jang; Joo Young Kim; Young Ho Byun; Ahyun Son; Jeong-Yoon Lee; Yoon Jae Lee; Jun Chang; Baik Lin Seong
Journal:  Front Immunol       Date:  2018-02-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.